These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8288206)

  • 1. [Pharmacokinetics of ciprofloxacin in young healthy volunteers].
    Liang D; Qin Y; Xu N; Zhang H; Li J
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):306-8. PubMed ID: 8288206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of ciprofloxacin injection in healthy volunteers].
    Hong Z; Wang Y; Xu N; Zhang H; Liang D
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):315-8. PubMed ID: 8586400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of high-pressure liquid chromatography and microbiological assay for determination of ciprofloxacin tablets in human plasma employed in bioequivalence and pharmacokinetics study.
    Khan MK; Khan MF; Mustafa G; Sualah M
    Pak J Pharm Sci; 2012 Jan; 25(1):81-8. PubMed ID: 22186313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the presence and pharmacokinetic profile of ciprofloxacin by TLC and HPLC method respectively in broiler chicken after single oral administration.
    Billah MM; Rana SM; Hossain MS; Saifuddin AK; Islam SK; Naim Z; Barua S
    J Antibiot (Tokyo); 2014 Nov; 67(11):745-8. PubMed ID: 24802212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
    Catchpole C; Andrews JM; Woodcock J; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers.
    Mostafavi A; Emami J; Varshosaz J; Davies NM; Rezazadeh M
    Int J Pharm; 2011 May; 409(1-2):128-36. PubMed ID: 21371548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects.
    Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1990; 23(12):1315-21. PubMed ID: 2136565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single and multiple dose pharmacokinetics of oral ciprofloxacin in elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Stein D; Breitenbucher R; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):279-84. PubMed ID: 3410603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2009 Jan; 22(1):1-7. PubMed ID: 19168412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC.
    Khan MK; Khan MF
    Pak J Pharm Sci; 2008 Jul; 21(3):299-306. PubMed ID: 18614429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ciprofloxacin in healthy Mexican volunteers.
    Escobar Y; Hoyo-Vadillo C
    Arzneimittelforschung; 2003; 53(9):664-7. PubMed ID: 14558441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate.
    Wong PY; Zhu M; Li RC
    J Chemother; 2000 Aug; 12(4):286-93. PubMed ID: 10949977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
    Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
    Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.